Table 3.
Comparison of antimicrobial activity between the studied groups.
Studied Group | G1 | G2 | G3 | G4 | G5 | G6 | G7 |
---|---|---|---|---|---|---|---|
methicillin-resistant Staphylococcus aureus (MRSA-ATCC® 43300) | |||||||
| |||||||
G1 | - | ≤0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
| |||||||
G2 | <0.001 | - | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
| |||||||
G3 | <0.001 | <0.001 | - | <0.001 | <0.001 | <0.001 | <0.001 |
| |||||||
G4 | <0.001 | <0.001 | <0.001 | - | <0.001 | <0.001 | <0.001 |
| |||||||
G5 | <0.001 | <0.001 | <0.001 | <0.001 | - | <0.001 | <0.001 |
| |||||||
G6 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | - | <0.001 |
| |||||||
G7 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | - |
| |||||||
methicillin-sensitive Staphylococcus aureus (MSSA-ATCC® 25923) | |||||||
| |||||||
G1 | - | <0.001 | <0.001 | <0.001 | 0.199 | <0.001 | <0.001 |
| |||||||
G2 | <0.001 | - | 0.002 | 0.002 | <0.001 | 0.042 | 0.002 |
| |||||||
G3 | <0.001 | 0.002 | - | AMR | <0.001 | 0.042 | AMR |
| |||||||
G4 | <0.001 | 0.002 | AMR | - | <0.001 | 0.042 | AMR |
| |||||||
G5 | 0.199 | <0.001 | <0.001 | <0.001 | - | <0.001 | <0.001 |
| |||||||
G6 | <0.001 | 0.042 | 0.042 | 0.042 | <0.001 | - | 0.042 |
| |||||||
G7 | <0.001 | 0.002 | AMR | AMR | <0.001 | 0.042 | - |
| |||||||
Enterococcus faecalis (ATCC® 29212) | |||||||
| |||||||
G1 | - | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
| |||||||
G2 | <0.001 | - | 0.021 | <0.001 | <0.001 | <0.001 | <0.001 |
| |||||||
G3 | <0.001 | 0.021 | - | <0.001 | <0.001 | 0.025 | <0.001 |
| |||||||
G4 | <0.001 | <0.001 | <0.001 | - | <0.001 | <0.001 | AMR |
| |||||||
G5 | <0.001 | <0.001 | <0.001 | <0.001 | - | <0.001 | <0.001 |
| |||||||
G6 | <0.001 | <0.001 | 0.025 | <0.001 | <0.001 | - | <0.001 |
| |||||||
G7 | <0.001 | <0.001 | <0.001 | AMR | <0.001 | <0.001 | - |
| |||||||
Pseudomonas aeruginosa (ATCC® 27853) | |||||||
| |||||||
G1 | - | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
| |||||||
G2 | <0.001 | - | 0.030 | <0.001 | <0.001 | <0.001 | <0.001 |
| |||||||
G3 | <0.001 | 0.030 | - | <0.001 | <0.001 | <0.001 | <0.001 |
| |||||||
G4 | <0.001 | <0.001 | <0.001 | - | <0.001 | 0.042 | AMR |
| |||||||
G5 | <0.001 | <0.001 | <0.001 | <0.001 | - | <0.001 | <0.001 |
| |||||||
G6 | <0.001 | <0.001 | <0.001 | 0.042 | <0.001 | - | 0.42 |
| |||||||
G7 | <0.001 | <0.001 | <0.001 | AMR | <0.001 | 0.042 | - |
The results are expressed as p, level of significance. In some cases p was not calculated because of the antimicrobial resistance (AMR) of both groups being compared. G1, L-PRP and 5 µl of autologous thrombin; G2, L-PRP and 2 µl of autologous thrombin; G3, liquid L-PRP; G4, autologous thrombin; G5, L-PRP and 5 µl of bovine thrombin in calcium chloride solution; G6, L-PRP and 2 µl of bovine thrombin in calcium chloride solution; G7; bovine thrombin.